Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meningococcal vaccines: a progress report.

Simone S Wildes1, Allan R Tunkel

  • 1Division of Infectious Diseases, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|November 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benefits, Challenges, and Opportunities of LCME Accreditation: A National Survey.

Medical science educator·2026
Same author

Perspectives in Brain Abscess Diagnosis and Management: A National Survey of Infectious Disease Specialists.

Open forum infectious diseases·2025
Same author

Maintenance of Certification: Is a Knowledge-Based Assessment Really Necessary?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

United States Medical Licensing Examination Performance and Outcomes of Patient Care.

Academic medicine : journal of the Association of American Medical Colleges·2024
Same author

Cefazolin for the Treatment of Central Nervous System Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2023
Same author

Perspectives on Diagnosis and Management of All-Cause Encephalitis: A National Survey of Adult Infectious Diseases Physicians.

Open forum infectious diseases·2023
Same journal

Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

An Overview and Trend Analysis of Biosimilar Approvals in China.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
See all related articles

Meningococcal conjugate vaccines offer improved prevention against invasive meningococcal disease, especially in young children. Routine infant vaccination shows significant efficacy in reducing disease incidence.

Area of Science:

  • Microbiology
  • Immunology
  • Public Health

Background:

  • Neisseria meningitidis is a significant cause of bacterial meningitis and septicaemia globally.
  • Serogroups A, B, C, and Y are responsible for most invasive meningococcal disease cases.
  • Emerging penicillin resistance in Neisseria meningitidis necessitates enhanced prevention strategies.

Purpose of the Study:

  • To evaluate the efficacy and impact of meningococcal conjugate vaccines.
  • To address limitations of polysaccharide vaccines in infants and young children.
  • To assess the effectiveness of routine meningococcal C conjugate vaccine programs.

Main Methods:

  • Review of existing literature on meningococcal vaccines.
  • Analysis of clinical trial data for meningococcal conjugate vaccines.

Related Experiment Videos

  • Post-licensure surveillance data analysis for vaccine impact.

    • Main Results:

    • Meningococcal conjugate vaccines are safe and immunogenic, providing T cell-dependent responses.
    • The meningococcal C conjugate vaccine has demonstrated significant efficacy in reducing invasive disease in vaccinated age groups.
    • Routine infant vaccination programs show early success in disease reduction.

    Conclusions:

    • Conjugate vaccines represent a significant advancement in controlling meningococcal disease.
    • Vaccination, particularly with conjugate vaccines, is the most effective strategy for meningococcal disease prevention.
    • Continued monitoring is essential to determine the full long-term impact of vaccination programs.